Atlas Trials

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

Clinical trial NCT00003007 · COMPLETED

Trial details

NCT number
NCT00003007
Sponsor
University of Tennessee
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma and Plasma Cell Neoplasm
Start date
1996-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.